Roche Working to Produce More Coronavirus Tests, Actemra
March 24 2020 - 3:00AM
Dow Jones News
By Cristina Roca
Roche Holding AG said Tuesday that it is working to speed up
production of a drug that could be used to treat patients with
coronavirus, as well as a diagnostic test.
Roche said it sees a potential increase in demand for Actemra,
which is currently in a Phase 3 study to test its safety and
efficacy in hospitalized adult patients with pneumonia caused by
the virus.
The company is working urgently to speed up manufacturing
capacity in order to maximize production of the drug, it said.
The Swiss pharmaceutical company said it is also working at
maximum production rate to make cobas(R) SARS-CoV-2 Test, a
diagnostic test for the virus. It is working to increase the number
of tests it can make every month, it said.
For now, Roche is experiencing limited disruption to its ability
to deliver medicines amid the pandemic, it said.
Write to Cristina Roca at cristina.roca@dowjones.com;
@_cristinaroca
(END) Dow Jones Newswires
March 24, 2020 02:45 ET (06:45 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2023 to Apr 2024
